0000950170-24-070626.txt : 20240607
0000950170-24-070626.hdr.sgml : 20240607
20240607161008
ACCESSION NUMBER: 0000950170-24-070626
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kapur Anil
CENTRAL INDEX KEY: 0001730703
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20859
FILM NUMBER: 241029458
MAIL ADDRESS:
STREET 1: 275 MADISON AVE
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GERON CORP
CENTRAL INDEX KEY: 0000886744
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 752287752
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6504737700
MAIL ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GERON CORPORATION
DATE OF NAME CHANGE: 19960521
4
1
ownership.xml
4
X0508
4
2024-06-06
0000886744
GERON CORP
GERN
0001730703
Kapur Anil
C/O GERON CORPORATION
919 E HILLSDALE BLVD. SUITE 250
FOSTER CITY
CA
94404
false
true
false
false
EVP, Corp Strategy & CCO
false
Employee Stock Option (right to buy)
1.43
2024-06-06
4
A
false
250000
0
A
2029-12-01
Common Stock
250000
250000
D
Performance-based stock option granted on December 2, 2019 and vested in full on June 6, 2024 upon approval of the NDA by the US FDA for imetelstat in lower risk MDS.
/s/ Scott A. Samuels for Anil Kapur
2024-06-07